跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXTROSE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DEXTROSE INJECTION
Authorized
STANDARD
DEXTROSE INJECTION
omega laboratories limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9ad3df5dfbeea2eb
Company
omega laboratories limited
Type
Standard
Approval Details
Approval Id
9ad3df5dfbeea2eb
Drug Approval Canada Name
DEXTROSE INJECTION
Product Name
DEXTROSE INJECTION
Status
Marketed
Status Date
2022-03-30
Original Market Date
2022-03-30
Din
02517132
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:20.00
Atc Original
B05BA03 CARBOHYDRATES
Atc Name
b 05 ba 03
Aig Number
0102181001
Company Name
omega laboratories limited
Company Address
11177 Hamon, Montreal, Quebec, Canada, H3M 3E4
Active Ingredients
DEXTROSE
50 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9ad3df5dfbeea2eb
Type
Standard
Back to Health Canada Approvals